BLFS
Price
$24.68
Change
+$0.50 (+2.07%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.18B
40 days until earnings call
NVCR
Price
$12.89
Change
+$0.11 (+0.86%)
Updated
Sep 26 closing price
Capitalization
1.44B
26 days until earnings call
Interact to see
Advertisement

BLFS vs NVCR

Header iconBLFS vs NVCR Comparison
Open Charts BLFS vs NVCRBanner chart's image
BioLife Solutions
Price$24.68
Change+$0.50 (+2.07%)
Volume$2.48K
Capitalization1.18B
NovoCure
Price$12.89
Change+$0.11 (+0.86%)
Volume$1.18M
Capitalization1.44B
BLFS vs NVCR Comparison Chart in %
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. NVCR commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Buy and NVCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (BLFS: $24.70 vs. NVCR: $12.89)
Brand notoriety: BLFS and NVCR are both not notable
BLFS represents the Pharmaceuticals: Other, while NVCR is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BLFS: 52% vs. NVCR: 65%
Market capitalization -- BLFS: $1.18B vs. NVCR: $1.44B
BLFS [@Pharmaceuticals: Other] is valued at $1.18B. NVCR’s [@Medical/Nursing Services] market capitalization is $1.44B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.13B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.44B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.83B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileNVCR’s FA Score has 1 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • NVCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLFS and NVCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 4 TA indicator(s) are bullish while NVCR’s TA Score has 4 bullish TA indicator(s).

  • BLFS’s TA Score: 4 bullish, 4 bearish.
  • NVCR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NVCR is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Pharmaceuticals: Other) experienced а -3.40% price change this week, while NVCR (@Medical/Nursing Services) price change was +1.58% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.13%. For the same industry, the average monthly price growth was -3.06%, and the average quarterly price growth was +8.48%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.97%. For the same industry, the average monthly price growth was +2.80%, and the average quarterly price growth was +8.73%.

Reported Earning Dates

BLFS is expected to report earnings on Nov 06, 2025.

NVCR is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-1.97% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCR($1.44B) has a higher market cap than BLFS($1.18B). BLFS YTD gains are higher at: -4.931 vs. NVCR (-56.745). BLFS has higher annual earnings (EBITDA): 17.4M vs. NVCR (-110.77M). NVCR has more cash in the bank: 912M vs. BLFS (81.8M). BLFS has less debt than NVCR: BLFS (23.8M) vs NVCR (700M). NVCR has higher revenues than BLFS: NVCR (630M) vs BLFS (93.5M).
BLFSNVCRBLFS / NVCR
Capitalization1.18B1.44B82%
EBITDA17.4M-110.77M-16%
Gain YTD-4.931-56.7459%
P/E RatioN/AN/A-
Revenue93.5M630M15%
Total Cash81.8M912M9%
Total Debt23.8M700M3%
FUNDAMENTALS RATINGS
BLFS vs NVCR: Fundamental Ratings
BLFS
NVCR
OUTLOOK RATING
1..100
6814
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
9298
PRICE GROWTH RATING
1..100
5964
P/E GROWTH RATING
1..100
138
SEASONALITY SCORE
1..100
8534

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BLFS's Valuation (99) in the Medical Specialties industry is in the same range as NVCR (100). This means that BLFS’s stock grew similarly to NVCR’s over the last 12 months.

BLFS's Profit vs Risk Rating (93) in the Medical Specialties industry is in the same range as NVCR (100). This means that BLFS’s stock grew similarly to NVCR’s over the last 12 months.

BLFS's SMR Rating (92) in the Medical Specialties industry is in the same range as NVCR (98). This means that BLFS’s stock grew similarly to NVCR’s over the last 12 months.

BLFS's Price Growth Rating (59) in the Medical Specialties industry is in the same range as NVCR (64). This means that BLFS’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's P/E Growth Rating (8) in the Medical Specialties industry is in the same range as BLFS (13). This means that NVCR’s stock grew similarly to BLFS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSNVCR
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 9 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SRUAX15.29N/A
N/A
Meeder Spectrum Adviser
FCAOX13.56N/A
N/A
Fidelity Advisor Climate Action M
JFAMX39.08N/A
N/A
JPMorgan Emerging Markets Equity A
LAVYX17.04N/A
N/A
Lord Abbett Fundamental Equity I
USMIX21.92N/A
N/A
Victory Extended Market Index

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+2.07%
RGEN - BLFS
59%
Loosely correlated
+3.25%
A - BLFS
51%
Loosely correlated
+1.22%
RVTY - BLFS
50%
Loosely correlated
+1.22%
TWST - BLFS
49%
Loosely correlated
+0.64%
AZTA - BLFS
49%
Loosely correlated
-0.73%
More

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with ITGR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
+0.86%
ITGR - NVCR
42%
Loosely correlated
-0.27%
AZTA - NVCR
39%
Loosely correlated
-0.66%
BLFS - NVCR
38%
Loosely correlated
+2.15%
TWST - NVCR
38%
Loosely correlated
+0.60%
TMCI - NVCR
37%
Loosely correlated
-0.30%
More